These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 15051739)

  • 21. Evidence-based emergency medicine review. Prevention of contrast-induced nephropathy in the emergency department.
    Sinert R; Doty CI
    Ann Emerg Med; 2007 Sep; 50(3):335-45, 345.e1-2. PubMed ID: 17512638
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Strategies to reduce the risk of contrast nephropathy: an evidence-based approach.
    Pannu N; Tonelli M
    Curr Opin Nephrol Hypertens; 2006 May; 15(3):285-90. PubMed ID: 16609296
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Radiocontrast nephropathy: identifying the high-risk patient and the implications of exacerbating renal function.
    Nikolsky E; Aymong ED; Dangas G; Mehran R
    Rev Cardiovasc Med; 2003; 4 Suppl 1():S7-S14. PubMed ID: 12556732
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Facts and fallacies concerning the prevention of contrast medium-induced nephropathy.
    Meschi M; Detrenis S; Musini S; Strada E; Savazzi G
    Crit Care Med; 2006 Aug; 34(8):2060-8. PubMed ID: 16763513
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preventing contrast medium-induced nephropathy.
    Kohtz C; Thompson M
    Am J Nurs; 2007 Sep; 107(9):40-9; quiz 49-50. PubMed ID: 17721148
    [No Abstract]   [Full Text] [Related]  

  • 26. Prevention of contrast media nephrotoxicity--the story so far.
    Morcos SK
    Clin Radiol; 2004 May; 59(5):381-9. PubMed ID: 15081843
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reno-protective effect of N-acetyl cysteine in patients with impaired renal function undergoing coronary angiography and interventions.
    Ramesh N; Pillai RK; Abraham T; Padmaja NP; Hameed S; Vijayaraghavan G
    J Assoc Physicians India; 2006 Jun; 54():449-52. PubMed ID: 16909692
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Adverse reactions to contrast material: recognition, prevention, and treatment.
    Maddox TG
    Am Fam Physician; 2002 Oct; 66(7):1229-34. PubMed ID: 12387435
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Use of N-acetylcysteine prior to cardiac catheterization to prevent acute renal injury in patients with stage III chronic kidney disease].
    Shavit L; Lifschitz M; Lachish T; Rosenmann D; Balkin J; Slotki I
    Harefuah; 2007 Sep; 146(9):655-9, 736. PubMed ID: 17969299
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prevention of contrast induced nephropathy: recommendations for the high risk patient undergoing cardiovascular procedures.
    Schweiger MJ; Chambers CE; Davidson CJ; Blankenship J; Bhalla NP; Block PC; Dervan JP; Gasperetti C; Gerber L; Kleiman NS; Krone RJ; Phillips WJ; Siegel RM; Uretsky BF; Laskey WK
    Catheter Cardiovasc Interv; 2007 Jan; 69(1):135-40. PubMed ID: 17139671
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-coronarography application of continuous veno-venous hemofiltration in the prevention of contrast nephropathy in patients with complex multisystem deficiency.
    La Manna G; Pancaldi L; Dalmastri V; Cuna V; Capecchi A; Comai G; Persici E; Bacchi G; Cianciolo G; Lombardi A; Marrozzini C; Colì L; Stefoni S
    In Vivo; 2008; 22(1):123-9. PubMed ID: 18396794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of N-acetylcysteine and hydration versus placebo and hydration in decreasing contrast-induced renal dysfunction in patients undergoing coronary angiography with or without concomitant percutaneous coronary intervention.
    Seyon RA; Jensen LA; Ferguson IA; Williams RG
    Heart Lung; 2007; 36(3):195-204. PubMed ID: 17509426
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Radiocontrast-induced nephropathy: current status and future prospects.
    Margulies K; Schirger J; Burnett J
    Int Angiol; 1992; 11(1):20-5. PubMed ID: 1387889
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-dialytic management of sepsis-induced acute kidney injury.
    Rajapakse S; Wijewickrama ES
    Saudi J Kidney Dis Transpl; 2009 Nov; 20(6):975-83. PubMed ID: 19861856
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Acetylcysteine and fenoldopam. Promising new approaches for preventing effects of contrast nephrotoxicity.
    Thompson EJ; King SL
    Crit Care Nurse; 2003 Jun; 23(3):39-46. PubMed ID: 12830779
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bench-to-bedside review: preventive measures for contrast-induced nephropathy in critically ill patients.
    van den Berk G; Tonino S; de Fijter C; Smit W; Schultz MJ
    Crit Care; 2005 Aug; 9(4):361-70. PubMed ID: 16137385
    [TBL] [Abstract][Full Text] [Related]  

  • 37. N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best?
    Shalansky SJ; Vu T; Pate GE; Levin A; Humphries KH; Webb JG
    Pharmacotherapy; 2005 Aug; 25(8):1095-103. PubMed ID: 16207100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The prevention of contrast-induced nephropathy in patients undergoing percutaneous coronary intervention.
    Cavusoglu E; Chhabra S; Marmur JD; Kini A; Sharma SK
    Minerva Cardioangiol; 2004 Oct; 52(5):419-32. PubMed ID: 15514576
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prevention and treatment of contrast-induced nephropathy.
    Al-Ghonaim M; Pannu N
    Tech Vasc Interv Radiol; 2006 Jun; 9(2):42-9. PubMed ID: 17482099
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Contrast media nephropathy: in depth review.
    Hussain N; Al Otaibi T; Nampoory MR
    Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):174-82. PubMed ID: 18310863
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.